Key Highlights

  • Qualcomm’s suit against Arm was due to go to a Delaware Jury on Friday after a five-day trial.
  • Qualcomm alleges Arm withheld patches and tools and broke an agreement to keep prices within 10 percent of the lowest.
  • Qualcomm also accuses Arm of leaking a 2024 breach letter to damage its dealings with Meta Platforms.
  • Qualcomm’s Arm license runs to 2033, and a ruling on halting royalties for five years is pending.

What the Jury Must Decide

A lawsuit by Qualcomm against Arm Holdings was due to go to a jury on Friday in federal court in Wilmington, Delaware, after a five-day trial. The jury is charged with deciding whether Arm breached its licensing agreements with Qualcomm and intentionally sabotaged some of Qualcomm’s dealings with Meta Platforms.

It is the second trial between the two companies in two years. The case highlights a deteriorating Business relationship that dates to SoftBank Group’s Acquisition of control of Arm in 2016 and Arm’s shift from licensing the technology needed to make chips to selling chips of its own. At stake is whether Qualcomm, whose license for Arm’s computing architecture runs until 2033, can eventually agree terms for new versions of that architecture.

Qualcomm’s Allegations

Qualcomm wants the jury to find that Arm breached the licensing agreements by Withholding software patches and tools for its designs. It also alleges that Arm violated an agreement meant to ensure Qualcomm paid within 10 percent of the lowest price for Arm’s processor designs.

A second claim centers on Meta. Qualcomm says Arm tried to torpedo its dealings with the Social Media company by leaking to a news outlet a 2024 letter in which Arm notified Qualcomm that it was allegedly in breach of a key license agreement. A Qualcomm lawyer said in opening statements that the company’s entire chip business depends on Arm and on Arm honoring its contract.

Arm’s Defense

Arm’s legal team spent this week steering jurors toward its argument that Qualcomm suffered no harm from the conduct it complains of. Arm cast the lawsuit as an attempt by Qualcomm to gain Leverage while the two companies negotiate licensing terms.

A Trial That Retraces Earlier Ground

The Delaware trial turned on many of the same episodes as the 2024 trial, in which Arm failed to convince a jury that Qualcomm had breached its licensing agreement with Arm. Both trials included testimony from Arm Chief Executive Rene Haas and Qualcomm Chief Executive Cristiano Amon, and both were overseen by US District Judge Maryellen Noreika.

Rulings Still Pending

Two matters remain open. Qualcomm asked Noreika to rule before trial that a clause in the licensing agreements lets it stop paying royalties for five years if the contract was breached. She has not ruled, and Arm argues the Royalty penalty is unenforceable. A related bench trial this week took up whether Arm is negotiating in good faith over licensing terms, and a decision on that can arrive well after the jury’s verdict.